SCHEMBL6601504

SCHEMBL6601504

NC1CCCC(C(=O)N(Cc2ccccc2)Cc2ccccc2)C1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
KDM4E B2RXH2 3/20 0.48
ALDH1A1 P00352 2/20 0.48
GAA P10253 2/20 0.48
ALOX12 P18054 1/20 0.48
HTT P42858 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
TRPM8 Q7Z2W7 5/20 0.44
USP2 O75604 1/20 0.43
HPGD P15428 1/20 0.43
LMNA P02545 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
OPRM1 P35372 1/20 0.43
OPRD1 P41143 1/20 0.43
CHRM5 P08912 1/20 0.43
LPAR1 Q92633 2/20 0.42
LPAR5 Q9H1C0 2/20 0.42
MC4R P32245 1/20 0.42
MC5R P33032 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5417761 0.99 MEN1 (0.56) MEN1KMT2AKDM4EALDH1A1GAA
SCHEMBL28694741 0.82 MEN1 (0.73) MEN1KMT2AKDM4EALDH1A1GAA
SCHEMBL9260456 0.80 MEN1 (0.69) MEN1KMT2AKDM4EALDH1A1GAA
SCHEMBL29764514 0.80 MEN1 (0.86) MEN1KMT2AKDM4EALDH1A1GAA
SCHEMBL6061686 0.80 MEN1 (0.86) MEN1KMT2AKDM4EALDH1A1GAA
SCHEMBL9260459 0.80 MEN1 (0.69) MEN1KMT2AKDM4EALDH1A1GAA
SCHEMBL12027654 0.77 POLB (0.55) MEN1KMT2AKDM4EALDH1A1HTT
SCHEMBL12027660 0.77 POLB (0.55) MEN1KMT2AKDM4EALDH1A1HTT
SCHEMBL16675681 0.77 POLB (0.55) MEN1KMT2AKDM4EALDH1A1HTT
SCHEMBL16689926 0.77 MC4R (0.56) TRPM8MC4RMC5RMC3RAGER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1403255-A1 Rho KINASE INHIBITORS SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2004-03-31 EP disclosed